MoneyWorks4Me

Gland Pharma informs about annual secretarial compliance report

27 May 2025 Evaluate
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Gland Pharma has enclosed the Secretarial Compliance Report for the financial year ended 31st March, 2025 issued by RVR & Associates, Company Secretaries. 

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..